DIN 02496135 — FASENRA PEN 30 MG
FASENRA PEN is a solution of Benralizumab marketed by ASTRAZENECA CANADA INC. The full Benralizumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02496135
- Brand name
- FASENRA PEN
- Active ingredient
- Benralizumab
- Strength
- 30 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- ASTRAZENECA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Anti-eosinophil biologic (interleukin-5 receptor alpha antagonist monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Benralizumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02473232 | FASENRA | 30 MG | SOLUTION | ASTRAZENECA CANADA INC | MARKETED |